Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nektar Therapeutics granted inducement awards to seven newly-hired employees on June 19, 2026, under its 2025 Inducement Plan. The awards include an aggregate of 20,500 non-qualified stock options and 3,900 restricted stock units.
Key figures
- Rsus granted
- 3900
- Exercise price
- 60.98
- Options granted
- 20500
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.